What Would You Do in the Event of Contamination?- An Interview with Lada Laenen




Pharmaceuticals & Biotechnology | Pharma & Biotech Resources show

Summary: In 2008 and 2009, Genzyme sites were affected by vesivirus infection. This shut down two sites for decontamination. In this candid interview, Lada Laenen, Managing Principal Scientist, Head, Cell Culture and Microbiology, Genzyme, a Sanofi Company, discusses how this